The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 350:1258-1259 March 18, 2004 Number 12
NextNext

Dysplastic Nevi

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Naeyaert, J. M.
-PubMed Citation
To the Editor: Naeyaert and Brochez (Dec. 4 issue)1 highlight the old published National Institutes of Health (NIH) guidelines for the management of dysplastic nevi but do not mention that since 1992 the NIH has recommended the elimination of the term.2 Indeed, the condition is not precisely defined by clinical morphology, dermatoscopy, or molecular biology. The NIH now considers dysplastic nevi to be one form of benign acquired melanocytic nevi and, by some analyses, the most common nevi found on humans.3,4 Of note, nuclear atypia is not a separate criterion for dysplastic nevi but rather can be seen with any . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.